Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Anthem

Centene

Humana

Magellan Health

Molina Healthcare

UnitedHealth Group

Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.

7 Health Insurers Poised to Beat Earnings Estimates in Q1

Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.

Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks

Equifax

United Technologies

Friday's big stock charts feature names that have struggled but could now be in the buy zone.
The post 3 Big Stock Charts for Friday: United Technologies, Cigna, and Equifax appeared first on InvestorPlace.

3 Big Stock Charts for Friday: United Technologies, Cigna, and Equifax

Cigna (CI) actively expands service suite for customers, thereby, helping contain the virus spread.

Cigna (CI) Ramps up Efforts to Contain Coronavirus Spread

The insurers could benefit from the move.

Cigna and Humana Join Aetna in Waiving COVID-19 Patients' Cost-Sharing Payments

Health insurance companies Cigna Corp. (NYSE: CI) and Humana Inc. (NYSE: HUM) will waive all out-of-pocket expenses for novel coronavirus (COVID-19) patients, President Donald Trump announced in a press conference on Sunday.

Insurers Cigna, Humana Waive Out-Of-Pocket Costs For Coronavirus Patients

The insurers said the waiver applies to all medical costs related to the treatment of coronavirus, including FDA-approved medications and vaccines when they become available.

Cigna and Humana waive coronavirus treatment costs

Health insurers Cigna and Humana are waiving customer cost-sharing and co-payments for all treatments related to the Coronavirus strain COVID-19.

Cigna, Humana Waive Patient Out-Of-Pocket Costs For All Coronavirus Treatment

Alexion Pharma

HCA Healthcare

A stock can be cheap but not be a bargain. At least two of these stocks appear to be both.

Should You Buy These 3 Dirt-Cheap Stocks?

Cigna (NYSE: CI) shares are trading higher after receiving an upgrade. Raymond James upgraded Cigna's stock from Outperform to Strong Buy.

Why Cigna's Stock Is Trading Higher Today

CVS Health

Those with private insurance who contract COVID-19 will get a lot of help from their insurers to cover the costs related to the disease.

Health Insurers Widen Coverage for COVID-19

Key developments by the U.S. government could have a profound impact on the country's health insurers.

Will Coronavirus Harm Health Insurers?

Cigna (CI) reported earnings 30 days ago. What's next for the stock?

Cigna (CI) Down 7.7% Since Last Earnings Report: Can It Rebound?

Investors are responding enthusiastically to the changing dynamics in the Democratic presidential race.

Here's Why Big Health Insurance Stocks Are Soaring Today

Cigna (CI) partners Houston Methodist to provide affordable health plans to its members.

Cigna Ties Up With Houston Methodist to Provide Quality Care

Health care plan stocks may see heightened volatility as Super Tuesday unfolds. Explore ideas to trade three prominent industry players.

Health Care Plan Stocks in Focus as Super Tuesday Looms

Cigna Corporation (CI) CEO David Cordani on Q4 2019 Results - Earnings Call Transcript

The health insurer's buyout of a leading pharmacy benefits manager in late 2018 made a big difference in its Q4 results.

Cigna's Express Scripts Acquisition Continues to Pay Off With Its Q4 Earnings Beat

Is  (CI) Outperforming Other Finance Stocks This Year?

Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

Cigna (CI) Q4 results reflect revenue and membership growth on the back of Express Scripts acquisition.

Cigna (CI) Q4 Earnings and Revenues Beat Estimates, Rise Y/Y

Aetna

Express Scripts Holding

Walgreens

WellCare Health Plans

The U.S. health insurance market, roiled by transformative deals in recent years, will likely face a lull in major deal activity in 2020 while firms await critical federal election outcomes.

Feel The Bern: Presidential Race Throws Cold Water On Health Insurance Mega-Mergers

Cigna CEO David Cordani said partnerships like its decision to sell new health plans with Oscar Health and its alliance with the pharmacy benefit manager Prime Therapeutics will escalate in 2020.

Cigna To Accelerate Partnership Strategy In 2020

The IBD SmartSelect Composite Rating for Cigna increased from 91 to 96 Wednesday. 
The post Cigna Composite Rating Climbs To Powerful 96 Amid Rising Profits appeared first on Investor's Business Daily.

Cigna Composite Rating Climbs To Powerful 96 Amid Rising Profits

Tenet Healthcare

A Bernie Sanders surge in the polls and the spreading coronavirus suddenly have UnitedHealth and other health care stocks looking ill.

Why UnitedHealth And Other Health Care Stocks Are Suddenly Looking ill

Cigna is trading within a buy area ahead of its upcoming quarterly report, expected around Feb. 6.
The post Cigna Trading Near Top Of Buy Zone With Earnings On Tap appeared first on Investor's Business Daily.

News for Cigna Stock (CI)